InSpark Technologies Announces the Results of the Home Use and Human Factors Study of Vigilant(TM) in People with Diabetes
June 11, 2016 11:00 ET | InSpark Technologies
Vigilant met or exceeded all human factors criteria for safety, comprehension and ease of useEarly evidence of clinical benefit was demonstrated by a 51 percent reduction in the proportion of blood...
InSpark Technologies Enters into Clinical Trial Collaborations to Study the Effectiveness of Mobile Health Technology in Preventing Low Blood Sugars in People With Diabetes
May 05, 2016 08:00 ET | InSpark Technologies
CHARLOTTESVILLE, Va., May 05, 2016 (GLOBE NEWSWIRE) -- InSpark Technologies, Inc. announced today that it has entered into clinical study collaborations with Atlanta Diabetes Associates, a large...
Hypo Risk Indicator graphic.jpg
New Vigilantâ„¢ Diabetes Management Companion Launched in U.S. That Alerts Users to Risk of Severe Hypoglycemia in Next 24 Hours
April 26, 2016 08:00 ET | InSpark Technologies
CHARLOTTESVILLE, Va., April 26, 2016 (GLOBE NEWSWIRE) -- InSpark Technologies, Inc., a leader in diabetes pattern recognition technology, today announced that VigilantTM1 is now available for...
InSpark Technologies Appoints Diabetes Experts to Inaugural Thought Leadership Council
April 26, 2016 08:00 ET | InSpark Technologies
CHARLOTTESVILLE, Va., April 26, 2016 (GLOBE NEWSWIRE) -- InSpark Technologies, a leader in diabetes advanced pattern recognition technology, today announced the formation of its Thought Leadership...
InSpark Technologies Presents Study Results Supporting the Utility of Its Hypo Risk Indicator at the Diabetes Technology Meeting
October 22, 2015 08:00 ET | InSpark Technologies
BETHESDA, Md., Oct. 22, 2015 (GLOBE NEWSWIRE) -- InSpark Technologies, Inc., a leader in diabetes pattern recognition technology, has announced it is presenting a poster at the Diabetes Technology...